Fiveyear denosumab treatment of postmenopausal women with osteoporosis: results from the first two years of the FREEDOM trial extension - Papapoulos, S; Chapurlat, R; Brand, ML (Osteoporosis Int, 2011)
Zugriff am 27.7.2011.